Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations
- 20 November 2022
- journal article
- review article
- Published by Elsevier in Translational Research
- Vol. 255, 171-180
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL148565)
- National Cancer Institute (K22CA258678)
- American Heart Association (940166, 979465)
- Genentech
- Fred Hutchinson Cancer Center
- University of Washington (R01HL146500)
This publication has 107 references indexed in Scilit:
- Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancerNature Genetics, 2014
- The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasmsLeukemia, 2014
- Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancyNature, 2014
- Identification of seven loci affecting mean telomere length and their association with diseaseNature Genetics, 2013
- Detectable clonal mosaicism from birth to old age and its relationship to cancerNature Genetics, 2012
- Detectable clonal mosaicism and its relationship to aging and cancerNature Genetics, 2012
- Fat tissue, aging, and cellular senescenceAging Cell, 2010
- Sequence variants at the TERT-CLPTM1L locus associate with many cancer typesNature Genetics, 2009
- PARP1 Val762Ala polymorphism reduces enzymatic activityBiochemical and Biophysical Research Communications, 2007
- Janus Kinase 2 Modulates the Apolipoprotein Interactions with ABCA1 Required for Removing Cellular CholesterolJournal of Biological Chemistry, 2004